ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0361

Transition in Focus: Health Care Utilization and Disease Status in Youth with Connective Tissue Diseases— A Single-Center Experience in British Columbia, Canada

Mercedes Chan1, Lori Tucker1, Jude AlMasoud1, Jaime Guzman2, Andrea Human1, David Cabral3, Angela How4, Wendy Wong5 and Jennifer Corpuz6, 1BC Children's Hospital, Vancouver, BC, Canada, 2University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada, 3BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 4UBC, Vancouver, BC, Canada, 5University of British Columbia, Surrey, BC, Canada, 6UBC, New Westminster, BC, Canada

Meeting: ACR Convergence 2025

Keywords: Access to care, autoimmune diseases, Health Care, Outcome measures, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Graduating from child and family-oriented to adult-oriented health care is a vulnerable time when youth with chronic disease drop out of, or disengage from, the healthcare system. For young adults with connective tissue diseases (CTD) in Vancouver, we developed a 3-phase “transition program” beginning in the multidisciplinary pediatric clinic; at end of high school patients transfer to a Young Adult Rheumatic Disease (YARD) clinic – a pediatric-adult hybrid-care transition clinic with no parental involvement; in 3-4 years they then transfer to adult care. This study describes healthcare use and disease outcomes of youth with CTD during the early phase of their transition through to the YARD clinic.

Methods: We conducted a retrospective chart review of patients who transitioned from pediatric care to the YARD clinic between 2013 and 2023. Comparative statistics were used to assess demographics, disease activity, and healthcare utilization (FU = follow-up visits, ED = emergency department, HA = hospital admission) one year pre- and post-transition. For study purposes, the first “transition” time point equates to the first YARD clinic visit.

Results: 42 patients were included (85.7% female) with systemic lupus erythematosus (SLE) (28/42), 66.7% juvenile dermatomyositis (14.3% linear scleroderma, 4.8% mixed connective tissue disease, and one patient each with cutaneous lupus, undifferentiated connective tissue disease, primary Sjogren’s, and systemic sclerosis. Mean transition age: 18 years (17.9-18). Patients attended an average of 4.19 FU visits pre-transition and 2.90 post-transition. The mean of missed rheumatology visits was 0.38 pre- and 0.41 post-transition (Table 1).For SLE patients, the median SLE Disease Activity Index (SLEDAI) scores were 4 pre- and 2 post-transition. Physician Global Assessment (PGA) scores were 1.14 pre- and 0.57 post-transition for all patients.ED visits occurred in 26.2% and 27.5% of patients pre- and post-transition, respectively, with 41.67% and 33.3% due to disease flare (Table 1). HA occurred in 11.9% and 7.7% pre- and post-transition, respectively, with 60% and 66.7% due to disease activity. There was no significant difference in ED or HA in the 12 months pre- vs. post-transition (p = 1.33 and 0.518). The YARD clinic received 40/42 (95.2%) patient referrals sent to the clinic. Post-transition, 30 patients remained in follow-up, 7 relocated or were transferred to a local physician, and 3 failed to show up despite repeated appointments.

Conclusion: In this cohort, initial transition from pediatric care to the YARD clinic was associated with stable ED use and HA rates. These findings suggest that our structured transition process is initially effective with minimal loss to follow-up and stable clinical outcomes. Our results highlight the need to evaluate the longer-term success of the YARD transition and subsequently after transfer to adult care.

Supporting image 1

Supporting image 2


Disclosures: M. Chan: None; L. Tucker: None; J. AlMasoud: None; J. Guzman: None; A. Human: None; D. Cabral: None; A. How: None; W. Wong: None; J. Corpuz: None.

To cite this abstract in AMA style:

Chan M, Tucker L, AlMasoud J, Guzman J, Human A, Cabral D, How A, Wong W, Corpuz J. Transition in Focus: Health Care Utilization and Disease Status in Youth with Connective Tissue Diseases— A Single-Center Experience in British Columbia, Canada [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/transition-in-focus-health-care-utilization-and-disease-status-in-youth-with-connective-tissue-diseases-a-single-center-experience-in-british-columbia-canada/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transition-in-focus-health-care-utilization-and-disease-status-in-youth-with-connective-tissue-diseases-a-single-center-experience-in-british-columbia-canada/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology